27 developer-"https:"-"https:"-"https:"-"HES-SO-Genève" positions at MASARYK UNIVERSITY
Sort by
Refine Your Search
-
focuses on research and development of cell and gene therapy for selected rare diseases. We are currently looking for a colleague to join our center who will contribute to the design, preparation
-
development of cell and gene therapy for selected rare diseases. We cooperate with the Fraunhofer Institute IZI (Germany), the University of Leipzig (Germany) and the University of Copenhagen (Denmark
-
of Excellence of the Faculty of Medicine of Masaryk University in Brno was established on 1 January 2024 and focuses on research and development of cell and gene therapy for selected rare diseases. Position
-
the workplace preparation of the study and teaching materials involvement in research and development activities, including the publication and presentation of research results share in the organizational
-
focuses on research and development of cell and gene therapy for selected rare diseases. We are currently looking for a colleague to join our center who will contribute to the design, preparation
-
for more effective treatments. One promising strategy involves mRNA-based cancer immunotherapy vaccines, which require a drug delivery system capable of reliably reaching the cytosol. Developing
-
working hours Support for further education and professional development Benefits package: 6 weeks of paid vacation, medical insurance, financial contribution to meal and kindergarten/pension scheme
-
and personal potential for development of the field and research, experience in education and research in the field, relevant educational, publishing and creative activities (including foreign
-
-cell imaging and high-resolution microscopy, you will uncover how these proteins reorganize in response to genotoxic stress and help safeguard the plant genome during development and replication
-
working hours 40 per week) The CREATIC Centre of Excellence of the Faculty of Medicine of Masaryk University in Brno was established on 1 January 2024 and focuses on research and development of cell and